Esco Technologies Inc: Form 10-Q for the period ended Mar 31, 2021
Filed with the SEC on May 7, 2021 and accepted by EDGAR at May 7, 2021, 10:56 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-01-01 to 2021-03-31 | $166.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2020-10-01 to 2021-03-31 | $329.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-01-01 to 2021-03-31 | $103.1m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2020-10-01 to 2021-03-31 | $201.9m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2021-01-01 to 2021-03-31 | $38.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2020-10-01 to 2021-03-31 | $79.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Income tax | 3 months2021-01-01 to 2021-03-31 | $5.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2020-10-01 to 2021-03-31 | $9.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-01-01 to 2021-03-31 | $16.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months2020-10-01 to 2021-03-31 | $30.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-01-01 to 2021-03-31 | $0.62 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2020-10-01 to 2021-03-31 | $1.15 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-01-01 to 2021-03-31 | $0.63 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2020-10-01 to 2021-03-31 | $1.15 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-01-01 to 2021-03-31 | 26,201,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2020-10-01 to 2021-03-31 | 26,192,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2020-10-01 to 2021-03-31 | $57.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2020-10-01 to 2021-03-31 | $13.2m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months2020-10-01 to 2021-03-31 | $4.2m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2021-03-31 | $45.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-03-31 | $428.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-03-31 | $1.36bn | us-gaap:Assets |
| Current liabilities | At period end2021-03-31 | $246.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-03-31 | $362.4m | us-gaap:Liabilities |
| Long-term debt | At period end2021-03-31 | $2.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2021-03-31 | $20.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2021-03-31 | $995.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-21-062898. Last ingested by Listed: Nov 3, 2026, 11:19 ET. Listed shows no prices and gives no investment advice.